Fig. 2From: The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumoursSLC7A5 copy number aberrations and relationship with mRNA expression in the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) cohort using one-way analysis of variance and the post-hoc Tukey testBack to article page